MyoStim Management Team
Alan Remen – CEO
Mr. Remen has over 25 years as a serial entrepreneur and business generalist with C level management experience in aerospace, agriculture, data communications, telecommunications, industrial instrumentation and out-sourced engineering services industries. In his aerospace company, Mr. Remen pioneered the reclamation of expensive hydraulic and dielectric fluids for the U.S. Military. In his agriculture company, Mr. Remen pioneered the continuous feeding of crops using liquid fertilizers dispensed in parts per million by a patented positive displacement, variable capacity pump into pressurized irrigation systems, thus vastly increasing the efficiency of the delivery of nutrients to crops. Mr. Remen’s data communications company pioneered in the hot replacement of redundant communication modules for high-density modem banks used extensively in the early days of the Internet. In addition, Mr. Remen brings international experience in Australia, Brazil, China, France, India, Germany, Italy, Japan, Korea, Malaysia, Mexico, Netherlands, Romania, Spain, Turkey and the UK. He currently also serves as the Managing Director of Private Capital Network (PCN), as Managing Director of Airspeed Equity, and as an Entrepreneur-in-Residence for CONNECT. Mr. Remen earned his degree in Business from San Diego State University after his service in the US Marine Corps.
Howard Leonhardt – Chairman & Chief Technology Officer
Howard J. Leonhardt, Chairman of the Board, Chief Technology Officer, MyoStim Pacers, Inc. & Chief Technology Officer, Chairman of the Scientific Board and Board Director, Bioheart, Inc. - An inventor and serial entrepreneur with over 20 patents for products for treating cardiovascular and heart disease. His TALENT stent graft for aortic aneurysm repair has treated over 120,000 patients worldwide since it's introduction in 1994 and holds a world leading market share today as part of Medtronic Vascular. In 1983 Leonhardt was Export Sales Manager, and the first founding employee, of American General Medical Corporation in Hardeeville, SC that built and supplied cardiac cath labs and intensive care units in foreign markets. In late 1984 he joined IMA Medical Group in Fort Lauderdale, Florida as VP of International Sales. In early 1986 he founded World Medical Corporation a firm which helped manufacturers of cardiovascular devices to reach export markets. In 1988 he invented an improved cardiovascular balloon catheter and founded World Medical Manufacturing Corporation in Sunrise, Florida, that went on to develop over a dozen cardiovascular products including the TALENT stent graft for repairing aortic aneuryms without surgery, the first percutaneous heart valve and the first stem cell delivery catheter systems ProCell. The firm grew from just 2 employees to over 500 and merged with Arterial Vascular Engineering of Santa Rosa, California in April of 1998. In November of 1998 the combined firms were acquired by Medtronic, Inc. of Minneapolis, Minnesota. Leonhardt served as President & CEO of World Medical Mfg. Corp. from 1988 until June of 1999. From November 1998 to June 1999 he duly held the position of Vice President of Emerging New Therapies at Medtronic, Inc. In June 1999 Leonhardt founded Bioheart, Inc. with a focus on utilizing living cells for cardiovasular and heart repair and personalized medical treatment. Leonhardt served as Executive Chairman and CEO up to Bioheart's IPO road show in 2007. He has since served as Chief Technology Officer, Chairman of the Scientific Advisory Board and as a member of the board of directors. Bioheart pioneered the introduction of the Pla2 genetic test to guide anti-blood clotting therapies in 2000. Bioheart has developed MyoCell and MyoCell SDF-1 for treating heart failure, the BioPace biological pacemaker, AortaCell aortic aneuerysm repair with cells, MyoValve heart valve repair with cells, EndoCell blood vessel repair with cells, HePoc heart pump on a catheter, LVSens implantable heart sensor, MyoStim Heart Repairing Electronic Pacemakers, and LipoCell for treating ischemia of the heart and legs. Many of these developments are based on Leonhardt's patented inventions or on patents he licensed. As Bioheart's CTO he is helping BIoheart to get license fees and partnerships to develop it's non-core technologies. MyoCell has advanced to Phase II/III clinical trials at 33 leading heart failure centers in the USA. MyoCell positive results have been published in numerous peer reviewed journals since clinical trials began in early 2001. As Chairman & CTO of MyoStim Pacers Leonhardt is advancing forward electrical stimulation technology that complements Bioheart's cell transplantation platform. MyoStim feeds royalty and milestone payments to Bioheart, Inc. by agreement. Leonhardt serves on various boards including the Cell Therapy Foundation. He holds a degree diploma in International Trade from Anoka Technical College in Minneapolis and attended the University of Minnesota and Anoka Ramsey Community College. He has an honorary Doctorate in Biomedical Engineering from the University of Northern California, and is an honorary alumnus of both the University of Florida and Florida International University where he has been a substantial contributor to their entrepreneurship programs. He also is a delegate to the White House StartUp America Partnership fostering entrepreneurship.
David W. Kramer - CFO
Mr. Kramer’s CFO experience spans 25 years of helping companies grow from start-up to over $100 million in sales, from high tech to life sciences. Most recently, he was CFO at Somanta Pharmaceuticals, Inc., a start-up, where he helped take the company through a reverse merger onto the NASDAQ. Earlier, at Anadys Pharmaceuticals, Inc., an emerging company, as CFO he helped raise $38 million in venture capital. Previously, at Gen-Probe, Inc., an international manufacturer and marketer of human diagnostic products, as CFO he assisted in the company’s growth from $5 million to $120 million in sales over 11 years. While there, he also served as CFO for a sister therapeutics company. Prior experience includes senior financial positions at Fujitsu Systems and in start-up electronics. Mr. Kramer has also consulted as a CFO for startups across a range of industries. He is a long-time volunteer at CONNECT Springboard, an incubator for small companies. Mr. Kramer’s memberships include Financial Executives International (20 years) and Corporate Directors Forum (5 years). He earned a BA, cum laude, from Yale and an MBA from Harvard Business School.
Tina Huth – Director, Corporate Development
Tina Huth is a leader in strategic planning and securing funding for research and development firms. During the past 15 years, she has assisted technology-based firms in growing research and improving infrastructure during start-up, restructuring, and growth phases in multiple industries - biotechnology, healthcare, defense, and higher education. At Celladon Corp, Xeris Pharmaceuticals, Avanir Pharmaceuticals, and Advanced Tissue Sciences, she was a key player in planning and developing research initiatives and contributed to the successful growth of sponsored research through securing federal grants. At M Ship Co., LLC, Ms. Huth was a key player in securing Department of Defense (DoD) funding and developing infrastructure processes and strategies to maintain contract management. At the University of California, San Diego, SDSU Research Foundation, and Children's Hospital, she managed research grants and assisted principal investigators with proposal development, federal compliance/guidelines, and fiscal/technical reporting. Ms. Huth remains an active member in several professional organizations including San Diego Biotech, Biocom, Connect, San Diego Chamber of Commerce, Society for Research Administrators (SRA), and the Regulatory Affairs Professional Society (RAPS). Additionally, she serves as a grant reviewer for CCAT (Center for Commercialization of Advanced Technologies) program. Funded by the Department of Defense, San Diego-based CCAT program identifies, evaluates, funds and fast-tracks the development of technologies for use by the DoD, the Department of Homeland Security (DHS), and the private sector.
Ms. Huth received her undergraduate degree from California State University, San Diego and her MBA from National University.
George Georgallides – International Business Development
Mr. Georgallides brings a global network of business contacts created through his international trade and HNW financial advisory experience. Additionally, Mr. Georgallides has been an active entrepreneur, starting businesses in international trade, information systems (websites) and media (animation, games). He has also worked as an insurance underwriter and a strategy consultant after his service in the Cyprus National Army. Mr. Georgallides earned a B.S. in Business Administration from the University of Southern California’s Marshall School of Business and an MBA in Entrepreneurship from Pepperdine’s Graziadio School of Business and Management. He is fluent in three languages: Greek, English and Spanish.
Brian Hardy - Marketing Communications
Mr. Hardy is a life long entrepreneur. Starting his first design and marketing company at the age of 18 in Fort Lauderdale, Florida. He has founded many businesses over the years including a trade show exhibit house creating custom exhibits for clients such as the United States Army, M & I Bank, Interactive Toys and many others. From 2005-2008 he owned & operated a full service sign company, creating custom signs for companies like Ben & Jerry's, Pita PIt, and Green Mountain Coffee. In 2008, he founded 4ColorFlyers.com. A fully-automated process allowing clients to track the progress of their print projects. 4 Color Flyers also does a wide variety of web design for clients such as LeonhardtVentures.com, CalStockExchange.com, HayleyBear.com, and LeonhardtVineyards.com. Mr. Hardy has over 13 years experience in graphic design, web design, and marketing industry.
Tom Newman – Sales
Tom Newman has over twenty years of sales and sales management expertise working with well known companies such as Johnson & Johnson, Pfizer, and Biomet. Tom has built two medical distribution companies and also has served as a business development leader for two small startup companies.
Jeff Donofrio – Sales
Jeff Donofrio has 25 years of Medical Sales and Sales management experience and has served as a senior consultant for several CardioVascular companies. These include WL Gore & Associates, Edwards Lifesciences and Cardiac Assist, Inc. Jeff was the co-founder of Big Sky Medical Inc. which was built and successfully sold for a nice profit to a larger company. He has experience in building both direct sales forces as well as distribution networks.